Joseph P. ST. LAURENT,Gerald S. JONES,David M. BRESSE
申请号：
US14644063
公开号：
US20150182488A1
申请日:
2015.03.10
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an ω-(methanesulfonyl)alkenylnitrile compound, or a pharmaceutically acceptable salt thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering an ω-(methanesulfonyl)alkenylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. Oral and topical administration are preferred.
